Identification and construction of a novel biomimetic delivery system of paclitaxel and its targeting therapy for cancer

Signal Transduct Target Ther. 2021 Jan 27;6(1):33. doi: 10.1038/s41392-020-00390-6.

Xue Wang^#¹, Wanwei Zheng^#², Qing Shen^#³, Yahua Wang¹, Yujen Tseng², Zhongguang Luo², Xiaoyou Wang¹, Lei Shi³, Chong Li^{4

5

6}, Jie Liu⁷

¹ Medical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China.
² Institute of Digestive Diseases, Huashan Hospital, Fudan University, Shanghai, 200041, China.
³ Hangzhou YITU Healthcare Technology Co., Ltd, Hangzhou, 310012, China.
⁴ Medical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China. [email protected].
⁵ State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, 450052, China. [email protected].
⁶ Xiamen Ginposome Pharmaceutical Co., Ltd, Xiamen, 361026, China. [email protected].
⁷ Institute of Digestive Diseases, Huashan Hospital, Fudan University, Shanghai, 200041, China. [email protected].

^# Contributed equally.

No abstract available

Publication types